Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5α-reductase II

Advances in Therapy

Volumn 27, Issue 8, 2010, Pages 555-563

  Pais, Pilar ^a  

^a Euromed   (Spain)

Author keywords

5 reductase; benign prostatic hyperplasia; prostate; saw palmetto ethanol extract; SPET 085

Indexed keywords

FINASTERIDE; SABAL EXTRACT; SPET 085; STEROID 5ALPHA REDUCTASE 2; UNCLASSIFIED DRUG;

ARTICLE; CELL FREE SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; EMBRYO; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MASS SPECTROMETRY; SABAL;

3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE; 5-ALPHA REDUCTASE INHIBITORS; ANDROGEN ANTAGONISTS; CELL-FREE SYSTEM; DRUG EVALUATION, PRECLINICAL; FINASTERIDE; HEK293 CELLS; HUMANS; MALE; PLANT EXTRACTS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 77956231681     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-010-0041-6     Document Type: Article

References (18)

1. T. Shirakawa H. Okada B. Acharya 2004 Messenger RNA levels and enzyme activities of 5 alphareductase types 1 and 2 in human benign prostatic hyperplasia (BPH) tissue Prostate 58 33 40 10.1002/pros.10313 14673950
2. C. Boudon J.M. Lobaccaro 1995 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates - effect of finasteride (Proscar), a 5 alpha-reductase inhibitor Cell Mol Biol 41 1007 1015 8747081
3. F. Comhaire A. Mahmoud 2004 Preventing diseases of the prostate in the elderly using hormones and nutriceuticals Aging Male 7 155 169 10.1080/13685530412331284722 15672940
4. J. Lee G. Andriole A. Avins 2009 Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia Clin Trials 6 628 636 10.1177/1740774509352199 20007408
5. J.L. Edwards 2008 Diagnosis and management of benign prostatic hyperplasia Am Fam Physician 77 1403 1410 18533373
6. M. Abe Y. Ito A. Suzuki 2009 Isolation and pharmacologic characterization of fatty acids from saw palmetto extract Anal Sci 25 553 557 10.2116/analsci.25.553 19359798
7. F. Scaglione V. Lucini M. Pannacci 2008 Comparison of the potency of different brands of Serenoa repens extract on 5alpha-reductase types I and II in prostatic co-cultured epithelial and fibroblast cells Pharmacology 82 270 275 10.1159/000161128 18849646
8. S. Bent C. Kane K. Shinohara 2006 Saw palmetto for benign prostatic hyperplasia N Engl J Med 354 557 566 10.1056/NEJMoa053085 16467543
9. T. Log 2008 Serenoa repens in benign prostatic hyperplasia Tidsskr Nor Laegeforen 128 1293 1294 18511974
10. W. Reichert R.W. Harmann J. Jose 2001 Stable expression of the human 5alpha-reductase isoenzymes type I and type II in HEK293 cells to identify dual and selective inhibitors Proc Natl Acad Sci U S A 16 47 53
11. S. Anderson D.W. Russell 1990 Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases Proc Natl Acad Sci U S A 87 3640 3644 10.1073/pnas.87.10.3640
12. S. Delos C. Lehle P.M. Martin 1994 Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells Steroid Biochem Mol Biol 48 347 352 10.1016/0960-0760(94)90074-4
13. F.K. Habib M. Ross C.K. Ho 2005 Serenoa repens (Permixon) inhibits the 5 alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression Int J Cancer 114 190 194 10.1002/ijc.20701 15543614
14. T.J. Wilt A. Ishani I. Rutks R. MacDonald 2000 Phytotherapy for benign prostatic hyperplasia Public Health Nutr 3 459 472 10.1017/S1368980000000549 11276294
15. G.S. Gerber D. Kuznetsov 2001 Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract infections Urology 58 960 964 10.1016/S0090-4295(01)01442-X 11744467
16. F. Hizli M.C. Uygur 2007 A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia Int Urol Nephrol 39 879 886 10.1007/s11255-006-9106-5 17203353
17. F.C. Lowe J.C. Ku 1996 Phytotherapy in treatment of benign prostatic hyperplasia: a critical review Urology 48 12 20 10.1016/S0090-4295(96)00077-5 8693632
18. Wilt T, Ishani A, MacDonald R. Serenoa repens for benign prostatic hyperplasia. Cochrane database Syst Rev. 2002;(3):CD001423.